CPH Pharma ApS: Financial statements 2022
CVR: 37110248
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,747,395 and a net result of DKK 586,524 compared with DKK 894,996 the year before. That is an increase of 10.8% compared with the year before. Equity in the 2022 report amounted to DKK 1,278,983. The solvency ratio was 67.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,747,395
- Profit/Loss
- DKK 586,524
- Equity
- DKK 1,278,983
- Total Assets
- DKK 1,893,043
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.7 mio. | 587 t. | 1.3 mio. | 2 |
| 2021 | - | 1.6 mio. | 895 t. | 1 mio. | 1 |
| 2020 | - | 1 mio. | 480 t. | 447 t. | 1 |
| 2019 | - | 799 t. | 575 t. | -33 t. | 1 |
| 2018 | - | -104 t. | -420 t. | -607 t. | 1 |
Keep an eye on CPH Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CPH Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,577,564, and the net result was DKK 894,996.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.